Working with a software consultancy that operates in 14 countries, the Department of Veterans Affairs has launched an interactive digital assistant to take U.S. veterans’ questions on COVID-19 and related concerns.

Researchers have demonstrated a smartphone application that monitors known heart failure by listening to patients’ voices for 30 seconds a day.

For AI to make a truly damaging dent in COVID-19’s armor, developers need to better connect big-data analytics with regularly refreshed input from frontline healthcare workers.

In a pilot study of 16 patients, the system’s recommendations were deemed safe by expert endocrinologists at a clip of more than 99% over the course of four weeks.

The authors further found that a majority of hospitals are now using standalone telemedicine products rather than those that are part of their EHR.

As part of its $5 million pandemic response, Amazon is placing more than 8,000 of its Echo Dot devices across dozens of senior-living facilities in parts of California and Washington State.

AI enthusiasts have varying aims and incentives for pushing the technology into healthcare, but many parrot a common set of justifications. Do any of these sound familiar?

After seeing telehealth visits skyrocket 3,700% in April over March—most of them COVID-related—UPMC is touting its use of AI to help patients retain and apply doctors’ guidance offered during virtual visits.

U.S. healthcare leadership missed opportunities for optimally promoting public health fairly early on in the present pandemic.

Despite the inroads AI has made into many medical specialties, the technology has failed to find a foothold in primary care. Why is that?

Fresh off an investment infusion of $25 million, a tech startup has launched an ambitious virtual consortium to seek “breakthrough medical discoveries and actionable findings” for the global battle against COVID-19. 

IBM has launched a blockchain-based network for healthcare organizations and government agencies looking to quickly find and hire alternative supply-chain sources during the public-health crisis set off by the COVID-19 outbreak.